reglab/housing_qa huggingface dataset:
NC Gen Stat § 90-113.52A (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.52A - Electronic record keeping.

 90-113.52A. Electronic record keeping.(a) A retailer shall, before completing a sale of a product containing a pseudoephedrine product, electronically submit the required information to the National Precursor Log Exchange (NPLEx) administered by the National Association of Drug Diversion Investigators (NADDI), provided that the NPLEx system is available to retailers in the State without a charge for accessing the system and the retailer has Internet access. The seller shall not complete the sale if the system generates a stop alert. Absent negligence, wantoness, recklessness, or deliberate misconduct, any retailer utilizing the electronic sales tracking system in accordance with this subsection shall not be civilly liable as a result of any act or omission in carrying out the duties required by this subsection and shall be immune from liability to any third party unless the retailer has violated any provision of this subsection in relation to a claim brought for such violation.(b) If a pharmacy selling a product containing a pseudoephedrine product experiences mechanical or electronic failure of the electronic sales tracking system and is unable to comply with the electronic sales tracking requirement, the pharmacy or retail establishment shall record that the sale was made without submission to the NPLEx system in the record of disposition required under G.S. 90-113.52.(c) The NADDI shall forward North Carolina transaction records in NPLEx to the State Bureau of Investigation weekly and provide real-time access to NPLEx information through the NPLEx online portal to law enforcement in the State as authorized by the SBI, provided that the SBI executes a memorandum of understanding with NADDI governing access.(d) This system shall be capable of generating a stop sale alert, which shall be a notification that completion of the sale would result in the seller or purchaser violating the quantity limits set forth in G.S. 90-113.52. The system shall contain an override function that may be used by a dispenser of a pseudoephedrine product who has a reasonable fear of imminent bodily harm if the dispenser does not complete a sale. Each instance in which the override function is utilized shall be logged by the system.  (2011-240, s. 2.)
NC Gen Stat § 90-113.53 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.53 - Pseudoephedrine transaction limits.

 90-113.53. Pseudoephedrine transaction limits.(a) No person shall deliver to any one person, attempt to deliver to any one person, purchase, or attempt to purchase at retail more than 3.6 grams of any pseudoephedrine products per calendar day. This limit does not apply if the product is dispensed under a valid prescription.(b) No person shall purchase at retail more than 9 grams of pseudoephedrine products within any 30-day period. This limit does not apply if the product is dispensed under a valid prescription.(c) This section does not apply to any pseudoephedrine products that are in the form of liquids, liquid capsules, gel capsules, or pediatric products labeled pursuant to federal regulation primarily intended for administration to children under 12 years of age according to label instruction, except as to those specific products for which the Commission issues an order pursuant to G.S. 90-113.58 subjecting the product to requirements under this Article.  (2005-434, s. 1; 2006-186, s. 2; 2012-35, s. 1.)
NC Gen Stat § 90-113.54 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.54 - Posting of signs.

 90-113.54. Posting of signs.(a) A retailer shall post a sign or placard in a clear and conspicuous manner in the area of the premises where the pseudoephedrine products are offered for sale substantially similar to the following: "North Carolina law strictly prohibits the purchase of more than 3.6 grams total of certain products containing pseudoephedrine per day, and more than 9 grams total of certain products containing pseudoephedrine within a 30-day period. This store will maintain a record of all sales of these products which may be accessible to law enforcement officers.(b) This section does not apply to any pseudoephedrine products that are in the form of liquids, liquid capsules, gel capsules, or pediatric products labeled pursuant to federal regulation primarily intended for administration to children under 12 years of age according to label instruction, except as to those specific products for which the Commission issues an order pursuant to G.S. 90-113.58 subjecting the product to requirements under this Article.  (2005-434, s. 1; 2006-186, s. 3; 2012-194, s. 60.5.)
NC Gen Stat § 90-113.55 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.55 - Training of employees.

 90-113.55. Training of employees.A retailer shall require that employees of the establishment involved in the sale of pseudoephedrine products in the form of tablets or caplets, and any other pseudoephedrine product for which the Commission issues an order pursuant to G.S. 90-113.58 to subject the product to requirements under this Article, be trained in a program conducted by or approved by the Commission pursuant to G.S. 90-113.59. (2005-434, s. 1.)
NC Gen Stat § 90-113.56 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.56 - Penalties.

 90-113.56. Penalties.(a) If a retailer willfully and knowingly violates the provisions of G.S. 90-113.52, 90-113.52A, 90-113.53, or 90-113.54, the retailer shall be guilty of a Class A1 misdemeanor for the first offense and a Class I felony for a second or subsequent offense. A retailer convicted of a third offense occurring on the premises of a single establishment shall be prohibited from making pseudoephedrine products available for sale at that establishment.(b) Any purchaser or employee who willfully and knowingly violates G.S. 90-113.52A, G.S. 90-113.52(c) or G.S. 90-113.53 shall be guilty of a Class 1 misdemeanor for the first offense, a Class A1 misdemeanor for a second offense, and a Class I felony for a third or subsequent offense. This subsection shall not be construed to apply to bona fide innocent purchasers.(c) A retailer who fails to train employees in accordance with G.S. 90-113.55, adequately supervise employees in transactions involving pseudoephedrine products, or reasonably discipline employees for violations of this Article shall be fined up to five hundred dollars ($500.00) for the first violation, up to seven hundred fifty dollars ($750.00) for the second violation, and up to one thousand dollars ($1,000) for a third or subsequent violation of this section.  (2005-434, s. 1; 2011-240, s. 3.)
NC Gen Stat § 90-113.57 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.57 - Immunity.

 90-113.57. Immunity.A retailer or an employee of the retailer who, reasonably and in good faith, reports to any law enforcement agency any alleged criminal activity related to the sale or purchase of pseudoephedrine products, or who refuses to sell a pseudoephedrine product to a person reasonably believed to be ineligible to purchase a pseudoephedrine product pursuant to this Article, is immune from civil liability for that conduct except in cases of willful misconduct. No retailer shall retaliate in any manner against any employee of the establishment for a report made in good faith to any law enforcement agency concerning alleged criminal activity related to the sale or purchase of pseudoephedrine products. (2005-434, s. 1.)
NC Gen Stat § 90-113.58 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.58 - Commission authority to control pseudoephedrine products.

 90-113.58. Commission authority to control pseudoephedrine products.(a) The Commission may add or delete a specific pseudoephedrine product from requirements of this Article on the petition of any interested party, or its own motion. In addition, the Commission may modify the specific storage, security, transaction limit, and record-keeping requirements applicable to a particular product upon such terms and conditions as they deem appropriate. In every case, the Commission shall give notice of and hold a public hearing pursuant to Chapter 150B of the General Statutes prior to adding or deleting a product. A petition by the Commission or the North Carolina Department of Justice to add or delete a specific product from requirements of this Article shall be placed on the agenda for consideration at the next regularly scheduled meeting of the Commission, as a matter of right. In making a determination regarding a specific product, the Commission shall consider whether or not there is substantial evidence that the specific product would be used to manufacture methamphetamine in the State.(b) In making a determination, the Commission shall make findings with respect thereto and shall issue an order adding or deleting the specific product from requirements of this Article. The order shall be published in the North Carolina Register at least 60 days prior to the time that the addition or deletion of a specific product from the requirements of this Article becomes effective.(c) The Commission may adopt temporary and permanent rules in accordance with this section. (2005-434, s. 1.)
NC Gen Stat § 90-113.59 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.59 - Commission development of employee training programs.

 90-113.59. Commission development of employee training programs.The Commission shall develop training and education programs targeted for employees of establishments where pseudoephedrine products are available for sale and shall approve such programs for implementation by retailers. The Commission may also conduct employee training programs for retail establishments. The Commission may adopt temporary and permanent rules in this regard. (2005-434, s. 1.)
NC Gen Stat § 90-113.60 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.60 - Preemption.

 90-113.60. Preemption.This Article shall preempt all local ordinances or regulations governing the sale by a retailer of over-the-counter products containing pseudoephedrine. (2005-434, s. 1.)
NC Gen Stat § 90-113.61 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.61 - Regulation of pseudoephedrine products in the form of liquids, liquid capsules, gel capsules, and pediatric products.

 90-113.61. Regulation of pseudoephedrine products in the form of liquids, liquid capsules, gel capsules, and pediatric products.Except as to those specific products for which the Commission issues an order pursuant to G.S. 90-113.58 subjecting the product to requirements under this Article, any pseudoephedrine products that are in the form of liquids, liquid capsules, gel capsules, or pediatric products labeled pursuant to federal regulation primarily intended for administration to children under 12 years of age according to label instruction shall not be subject to requirements under this Article, but such products shall be subject to the requirements of the Combat Methamphetamine Act of 2005, Title VII of the USA PATRIOT Improvement and Reauthorization Act of 2005, P.L. 109-177. (2006-186, s. 4.)
NC Gen Stat § 90-113.64 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5D - Control of Methamphetamine Precursors.|§ 90-113.64 - SBI annual report.

 90-113.64. SBI annual report.Beginning with the 2011 calendar year, the State Bureau of Investigation shall determine the number of methamphetamine laboratories discovered in the State each calendar year and report its findings to the Joint Legislative Oversight Committee on Justice and Public Safety by March 1, 2012, for the 2011 calendar year and each March 1 thereafter for the preceding calendar year. The State Bureau of Investigation shall participate in the High Intensity Drug Trafficking Areas (HIDTA) program, assist in coordinating the drug control efforts between local and State law enforcement agencies, and monitor the implementation and effectiveness of the electronic record-keeping requirements included in G.S. 90-113.52A and G.S. 90-113.56. The SBI shall include its findings in the report to the Commission required by this section.  (2011-240, s. 4; 2015-241, s. 16B.5(b); 2021-90, s. 8(b).)
NC Gen Stat § 90-113.70 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5E - North Carolina Controlled Substances Reporting System Act.|§ 90-113.70 - Short title.

 90-113.70. Short title.This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System Act." (2005-276, s. 10.36(a).)
NC Gen Stat § 90-113.71 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5E - North Carolina Controlled Substances Reporting System Act.|§ 90-113.71 - Legislative findings and purpose.

 90-113.71. Legislative findings and purpose.(a) The General Assembly makes the following findings:(1) North Carolina is experiencing an epidemic of poisoning deaths from unintentional drug overdoses.(2) Since 1997, the number of deaths from unintentional drug overdoses has increased threefold, from 228 deaths in 1997 to 690 deaths in 2003.(3) The number of unintentional deaths from illicit drugs in North Carolina has decreased since 1992 while unintentional deaths from licit drugs, primarily prescriptions, have increased.(4) Licit drugs are now responsible for over half of the fatal unintentional poisonings in North Carolina.(5) Over half of the prescription drugs associated with unintentional deaths are narcotics (opioids).(6) Of these licit drugs, deaths from methadone, usually prescribed as an analgesic for severe pain, have increased sevenfold since 1997.(7) Methadone from opioid treatment program clinics is a negligible source of the methadone that has contributed to the dramatic increase in unintentional methadone-related deaths in North Carolina.(8) Review of the experience of the 19 states that have active controlled substances reporting systems clearly documents that implementation of these reporting systems do not create a "chilling" effect on prescribing.(9) Review of data from controlled substances reporting systems help:a. Support the legitimate medical use of controlled substances.b. Identify and prevent diversion of prescribed controlled substances.c. Reduce morbidity and mortality from unintentional drug overdoses.d. Reduce the costs associated with the misuse and abuse of controlled substances.e. Assist clinicians in identifying and referring for treatment patients misusing controlled substances.f. Reduce the cost for law enforcement of investigating cases of diversion and misuse.g. Inform the public, including health care professionals, of the use and abuse trends related to prescription drugs.(b) This Article is intended to improve the State's ability to identify controlled substance abusers or misusers and refer them for treatment, and to identify and stop diversion of prescription drugs in an efficient and cost-effective manner that will not impede the appropriate medical utilization of licit controlled substances. (2005-276, s. 10.36(a).)
NC Gen Stat § 90-113.72 (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5E - North Carolina Controlled Substances Reporting System Act.|§ 90-113.72 - Definitions.

 90-113.72. Definitions.The following definitions apply in this Article:(1) Commission. - The Commission for Mental Health, Developmental Disabilities, and Substance Abuse Services established under Part 4 of Article 3 of Chapter 143B of the General Statutes.(2) Controlled substance. - A controlled substance as defined in G.S. 90-87(5).(3) Department. - The Department of Health and Human Services.(4) Dispenser. - A person who delivers a Schedule II through V controlled substance to an ultimate user in North Carolina, but does not include any of the following:a. A licensed hospital or long-term care pharmacy that dispenses such substances for the purpose of inpatient administration.b. Repealed by Session Laws 2013-152, s. 1, effective January 1, 2014, and applicable to prescriptions delivered on or after that date.c. A wholesale distributor of a Schedule II through V controlled substance.d. A person licensed to practice veterinary medicine pursuant to Article 11 of Chapter 90 of the General Statutes.(4a) Pharmacy. - A person or entity holding a valid pharmacy permit pursuant to G.S. 90-85.21 or G.S. 90-85.21A.(5) Ultimate user. - A person who has lawfully obtained, and who possesses, a Schedule II through V controlled substance for the person's own use, for the use of a member of the person's household, or for the use of an animal owned or controlled by the person or by a member of the person's household.  (2005-276, s. 10.36(a); 2013-152, s. 1; 2017-74, s. 9.)
NC Gen Stat § 90-113.73A (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5E - North Carolina Controlled Substances Reporting System Act.|§ 90-113.73A - Expand monitoring capacity; report.

 90-113.73A. Expand monitoring capacity; report.(a) The North Carolina Controlled Substances Reporting System shall expand its monitoring capacity by establishing data use agreements with the Prescription Behavior Surveillance System. In order to participate, the CSRS shall establish a data use agreement with the Center of Excellence at Brandeis University no later than January 1, 2016.(b) Repealed by Session Laws 2020-78, s. 4B.1(a), effective July 1, 2020.  (2015-241, s. 12F.16(j), (k); 2020-78, s. 4B.1(a).)
NC Gen Stat § 90-113.74A (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5E - North Carolina Controlled Substances Reporting System Act.|§ 90-113.74A - Mandatory prescriber registration for access to controlled substances reporting system.

 90-113.74A. Mandatory prescriber registration for access to controlled substances reporting system.Within 30 days after obtaining an initial or renewal license that confers the authority to prescribe a controlled substance for the purpose of providing medical care for a patient, the licensee shall demonstrate to the satisfaction of the licensing board that he or she is registered for access to the controlled substances reporting system. A violation of this section may constitute cause for the licensing board having jurisdiction over the licensee to suspend or revoke the license.  (2016-94, s. 12F.7(c).)
NC Gen Stat § 90-113.74B (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5E - North Carolina Controlled Substances Reporting System Act.|§ 90-113.74B - Mandatory dispenser registration for access to controlled substances reporting system; exception.

 90-113.74B. Mandatory dispenser registration for access to controlled substances reporting system; exception.(a) Within 30 days after obtaining an initial or renewal license to practice pharmacy, the licensee shall demonstrate to the satisfaction of the North Carolina Board of Pharmacy that he or she is registered for access to the controlled substances reporting system. A violation of this section may constitute cause for the Board of Pharmacy to suspend or revoke the license.(b) This section does not apply to a licensee employed in a pharmacy practice setting where a Schedule II, III, or IV controlled substance will not be dispensed.  (2017-74, s. 12.)
NC Gen Stat § 90-113.74C (2021)
2021 North Carolina General Statutes|Chapter 90 - Medicine and Allied Occupations|Article 5E - North Carolina Controlled Substances Reporting System Act.|§ 90-113.74C - Practitioner use of controlled substances reporting system; mandatory reporting of violations.

 90-113.74C. Practitioner use of controlled substances reporting system; mandatory reporting of violations.(a) Prior to initially prescribing a targeted controlled substance to a patient, a practitioner shall review the information in the controlled substances reporting system pertaining to the patient for the 12-month period preceding the initial prescription. For every subsequent three-month period that the targeted controlled substance remains a part of the patient's medical care, the practitioner shall review the information in the controlled substances reporting system pertaining to the patient for the 12-month period preceding the determination that the targeted controlled substance should remain a part of the patient's medical care. Each instance in which the practitioner reviews the information in the controlled substances reporting system pertaining to the patient shall be documented in the patient's medical record. In the event the practitioner is unable to review the information in the controlled substances reporting system pertaining to the patient because the system is not operational or there is some other temporary electrical or technological failure, this inability shall be documented in the patient's medical record. Once the electrical or technological failure has been resolved, the practitioner shall review the information in the controlled substances reporting system pertaining to the patient and the review shall be documented in the patient's medical record.(b) A practitioner may, but is not required to, review the information in the controlled substances reporting system pertaining to a patient prior to prescribing a targeted controlled substance to the patient in any of the following circumstances:(1) The controlled substance is to be administered to a patient in a health care setting, hospital, nursing home, outpatient dialysis facility, or residential care facility, as defined in G.S. 14-32.2.(2) The controlled substance is prescribed for the treatment of cancer or another condition associated with cancer.(3) The controlled substance is prescribed to a patient in hospice care or palliative care.(c) The Department shall conduct periodic audits of the review of the controlled substances reporting system by prescribers. The Department shall determine a system for selecting a subset of prescriptions to examine during each auditing period. The Department shall report to the appropriate licensing board any prescriber found to be in violation of this section. A violation of this section may constitute cause for the licensing board to suspend or revoke a prescriber's license.(d) For purposes of this section, a "practitioner" does not include a person licensed to practice veterinary medicine pursuant to Article 11 of Chapter 90 of the General Statutes.  (2017-74, s. 12; 2018-76, s. 4.)